<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Infants of mothers with diabetes (IMD)
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Infants of mothers with diabetes (IMD)
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Infants of mothers with diabetes (IMD)
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Arieh Riskin, MD, MHA, PhD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Joseph A Garcia-Prats, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Joseph I Wolfsdorf, MD, BCh
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Carrie Armsby, MD, MPH
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            May 04, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Diabetes in pregnancy is associated with an increased risk of fetal, neonatal, and long-term complications in the offspring. Maternal diabetes may be pregestational (ie, type 1 or type 2 diabetes mellitus [DM] diagnosed before pregnancy) or gestational (ie, DM diagnosed during pregnancy). The outcome is generally related to the onset and duration of glucose intolerance during pregnancy and maternal glycemic control. (See
         <a class="medical medical_review" href="/z/d/html/94859.html" rel="external">
          "Pregestational (preexisting) diabetes: Preconception counseling, evaluation, and management"
         </a>
         .)
        </p>
        <p>
         This topic will review the complications seen in infants of mothers with diabetes (IMD). The prenatal management of pregestational and gestational diabetes mellitus is discussed in separate topic reviews:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/6797.html" rel="external">
          "Gestational diabetes mellitus: Screening, diagnosis, and prevention"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/4800.html" rel="external">
          "Gestational diabetes mellitus: Obstetric issues and management"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/6790.html" rel="external">
          "Gestational diabetes mellitus: Glucose management and maternal prognosis"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/94859.html" rel="external">
          "Pregestational (preexisting) diabetes: Preconception counseling, evaluation, and management"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/4806.html" rel="external">
          "Pregestational (preexisting) diabetes mellitus: Obstetric issues and management"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3364305051">
         <span class="h1">
          IMPACT OF MATERNAL DIABETES STATUS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The risk of complications in the offspring varies considerably depending upon whether the mother has pregestational or gestational diabetes mellitus (PGDM or GDM), whether the mother is insulin-dependent, and the degree of glycemic control achieved before and during pregnancy. Infants born to mothers with PGDM (ie, type 1 or type 2 DM diagnosed before pregnancy) have a higher risk of mortality and diabetes-related complications (eg, macrosomia, preterm birth, congenital abnormalities, and respiratory distress) compared with offspring of mothers with GDM [
         <a href="#rid1">
          1-7
         </a>
         ]. The risk is particularly high in infants born to mothers with insulin-dependent DM and those with poor glycemic control before and during pregnancy. For infants born to mothers with GDM not requiring insulin, the risk of neonatal complications is modestly increased compared with the general population [
         <a href="#rid2">
          2,6
         </a>
         ]. Strict glycemic control preconception and during pregnancy reduces the risk of perinatal mortality and morbidity. (See
         <a class="medical medical_review" href="/z/d/html/6797.html" rel="external">
          "Gestational diabetes mellitus: Screening, diagnosis, and prevention"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6790.html" rel="external">
          "Gestational diabetes mellitus: Glucose management and maternal prognosis", section on 'Rationale for treatment'
         </a>
         .)
        </p>
        <p>
         The impact of maternal diabetes status on neonatal outcomes was demonstrated in two population-based studies from France and Finland that included data on &gt;160,000 infants born to mothers with diabetes (IMD) [
         <a href="#rid2">
          2,6
         </a>
         ]. Among the 5291 infants born to mothers with type 1 DM, 36 percent were born preterm (&lt;37 weeks gestation) and 41 percent were large for gestational age (LGA). By contrast, among the 5647 infants born to women with type 2 DM, 13 percent were preterm and 18 percent were LGA. Among the 151,056 infants born to women with GDM, 6 percent were preterm and 9 percent were LGA, rates that are only modestly higher than rates seen in the nondiabetic population (5 and 6 percent, respectively).
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h1">
          FETAL EFFECTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Poor glycemic control in pregnant individuals with diabetes leads to adverse fetal effects throughout pregnancy, as follows [
         <a href="#rid8">
          8
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          First trimester
         </strong>
         – In the first trimester and time of conception, maternal hyperglycemia can cause diabetic embryopathy, resulting in major birth defects and spontaneous abortions  (
         <a class="graphic graphic_table graphicRef62158" href="/z/d/graphic/62158.html" rel="external">
          table 1
         </a>
         ). This primarily occurs in pregnancies with pregestational diabetes mellitus (PGDM) [
         <a href="#rid1">
          1,9,10
         </a>
         ]. The risk for congenital malformations associated with gestational diabetes mellitus (GDM) is only slightly increased compared with the general population. The risk of malformations increases as maternal fasting blood glucose levels and body mass index (BMI) increases when GDM is diagnosed early in pregnancy. These findings suggest that some of these mothers probably have undiagnosed type 2 DM [
         <a href="#rid11">
          11,12
         </a>
         ]. (See
         <a class="local">
          'Congenital abnormalities'
         </a>
         below and
         <a class="medical medical_review" href="/z/d/html/94859.html" rel="external">
          "Pregestational (preexisting) diabetes: Preconception counseling, evaluation, and management"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Second and third trimester
         </strong>
         – Diabetic fetopathy occurs in the second and third trimesters, resulting in fetal hyperglycemia, hyperinsulinemia, and macrosomia.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Effects of fetal hyperinsulinemia
         </strong>
         – Maternal hyperglycemia leads to fetal hyperglycemia resulting in fetal hyperinsulinemia and, after delivery, neonatal hypoglycemia. (See
         <a class="local">
          'Hypoglycemia'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         Fetal hyperinsulinemia stimulates storage of glycogen in the liver, increased activity of hepatic enzymes involved in lipid synthesis, and accumulation of fat in adipose tissue. These metabolic effects might contribute to long-term metabolic complications in the offspring. (See
         <a class="local">
          'Metabolic risks'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         Fetal hyperinsulinemia also increases the synthesis and deposition of fat and glycogen in the myocardial cells, which can lead to ventricular hypertrophy [
         <a href="#rid13">
          13
         </a>
         ]. Fetal echocardiography may show evidence of hypertrophy starting at the end of the second and the beginning of the third trimester. Hypertrophy is characterized by marked thickening of the interventricular septum (IVS) [
         <a href="#rid14">
          14
         </a>
         ]. In one study, prenatal echocardiographic measurements of IVS thickness performed at ≥35 weeks gestation correlated with risk of postnatal cardiac morbidity [
         <a href="#rid15">
          15
         </a>
         ]. (See
         <a class="local">
          'Ventricular hypertrophy'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         Fetal hyperinsulinemia is also thought to contribute to impaired or delayed lung maturation. (See
         <a class="local">
          'Respiratory distress syndrome'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Fetal hypoxemia
         </strong>
         – Animal studies have shown that chronic fetal hyperinsulinemia results in elevated metabolic rates that lead to increased oxygen consumption and fetal hypoxemia, as the placenta may be unable to meet the increased metabolic demands [
         <a href="#rid16">
          16
         </a>
         ]. Fetal hypoxemia contributes metabolic acidosis, alterations in fetal iron distribution, increased erythropoiesis, and increased risk of fetal demise [
         <a href="#rid17">
          17
         </a>
         ]. Stillbirth is more likely in pregnancies complicated by poorly controlled diabetes. (See
         <a class="medical medical_review" href="/z/d/html/4800.html" rel="external">
          "Gestational diabetes mellitus: Obstetric issues and management", section on 'Fetal surveillance'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4806.html" rel="external">
          "Pregestational (preexisting) diabetes mellitus: Obstetric issues and management", section on 'Risk of stillbirth'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Increased erythropoiesis
         </strong>
         – Increased synthesis of erythropoietin leads to polycythemia and increased catecholamine production, which can result in hypertension and cardiac hypertrophy [
         <a href="#rid18">
          18,19
         </a>
         ]. (See
         <a class="local">
          'Polycythemia'
         </a>
         below and
         <a class="local">
          'Ventricular hypertrophy'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         As the fetal red cell mass increases, iron redistribution results in iron deficiency in developing organs, which may contribute to altered cardiac and neurologic development [
         <a href="#rid17">
          17
         </a>
         ]. (See
         <a class="local">
          'Congenital abnormalities'
         </a>
         below and
         <a class="local">
          'Ventricular hypertrophy'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Oxidative stress
         </strong>
         – Oxidative stress may play a role in maternal and fetal complications of pregnancies complicated by diabetes [
         <a href="#rid20">
          20,21
         </a>
         ]. For example, increased generation of reactive oxygen species with inadequate antioxidant defenses in the fetal heart might lead to abnormal cardiac remodeling and ventricular hypertrophy [
         <a href="#rid12">
          12,22
         </a>
         ]. (See
         <a class="local">
          'Congenital abnormalities'
         </a>
         below and
         <a class="local">
          'Ventricular hypertrophy'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         Oxidative stress also contributes to increased erythropoietin production with resultant polycythemia [
         <a href="#rid22">
          22,23
         </a>
         ]. (See
         <a class="local">
          'Polycythemia'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Excess nutrients
         </strong>
         – Excessive nutrients delivered from the mother with poorly controlled diabetes cause increased fetal growth, particularly of insulin-sensitive tissues (ie, liver, muscle, cardiac muscle, and subcutaneous fat), resulting in macrosomia  (
         <a class="graphic graphic_picture graphicRef54212" href="/z/d/graphic/54212.html" rel="external">
          picture 1
         </a>
         ). (See
         <a class="local">
          'Macrosomia'
         </a>
         below and
         <a class="medical medical_review" href="/z/d/html/94859.html" rel="external">
          "Pregestational (preexisting) diabetes: Preconception counseling, evaluation, and management"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H8">
         <span class="h1">
          NEONATAL COMPLICATIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Infants of mothers with diabetes (IMD) are at increased risk for congenital anomalies, mortality, and morbidity compared with infants born to mothers without diabetes  (
         <a class="graphic graphic_table graphicRef80370" href="/z/d/graphic/80370.html" rel="external">
          table 2
         </a>
         ). Neonatal complications of IMD include  (
         <a class="graphic graphic_table graphicRef80370" href="/z/d/graphic/80370.html" rel="external">
          table 2
         </a>
         ) [
         <a href="#rid24">
          24
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Congenital abnormalities (see
         <a class="local">
          'Congenital abnormalities'
         </a>
         below)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Prematurity (see
         <a class="local">
          'Prematurity'
         </a>
         below)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Perinatal asphyxia (see
         <a class="local">
          'Perinatal asphyxia'
         </a>
         below)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Macrosomia (see
         <a class="local">
          'Macrosomia'
         </a>
         below)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Birth injury (largely due to macrosomia) (see
         <a class="local">
          'Birth injury'
         </a>
         below)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Respiratory distress (see
         <a class="local">
          'Respiratory distress'
         </a>
         below)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Metabolic complications (eg, hypoglycemia and hypocalcemia) (see
         <a class="local">
          'Metabolic complications'
         </a>
         below)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Polycythemia (see
         <a class="local">
          'Polycythemia'
         </a>
         below)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Low iron stores (see
         <a class="local">
          'Low iron stores'
         </a>
         below)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Hyperbilirubinemia (see
         <a class="local">
          'Hyperbilirubinemia'
         </a>
         below)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Ventricular hypertrophy (see
         <a class="local">
          'Ventricular hypertrophy'
         </a>
         below)
        </p>
        <p>
        </p>
        <p>
         Although there have been advances in treatment of pregestational diabetes mellitus (PGDM) and screening and treatment of gestational diabetes mellitus (GDM), neonatal complications and congenital abnormalities continued to be observed in pregnancies complicated by diabetes and these complications contribute to a reported perinatal mortality rate that ranges from 0.5 to 2.5 percent in this population [
         <a href="#rid2">
          2
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H9">
         <span class="h2">
          Congenital abnormalities
         </span>
         <span class="headingEndMark">
          —
         </span>
         IMD are at increased risk for major congenital abnormalities  (
         <a class="graphic graphic_table graphicRef62158" href="/z/d/graphic/62158.html" rel="external">
          table 1
         </a>
         ) [
         <a href="#rid17">
          17
         </a>
         ]. The overall risk for major congenital malformations among IMD is approximately 5 to 6 percent, with a higher prevalence (10 to 12 percent) among IMD whose mothers require insulin therapy [
         <a href="#rid1">
          1,4,24,25
         </a>
         ]. These rates are substantially higher than in the general population, for whom the prevalence of major congenital abnormalities is approximately 2 to 4 percent among all livebirths. (See
         <a class="medical medical_review" href="/z/d/html/110898.html" rel="external">
          "Congenital anomalies: Epidemiology, types, and patterns", section on 'Epidemiology'
         </a>
         .)
        </p>
        <p>
         The risk of congenital abnormalities is related to maternal hyperglycemia at the time of conception and during early gestation. The risk is highest among IMD whose mothers had pregestational diabetes (approximately three-fold higher than the general newborn population) [
         <a href="#rid26">
          26
         </a>
         ].
        </p>
        <p>
         Congenital malformations account for approximately 50 percent of perinatal deaths in IMD [
         <a href="#rid27">
          27
         </a>
         ]. This risk can be reduced by strict glycemic control during the pre- and periconceptual (first eight weeks of pregnancy) periods. (See
         <a class="medical medical_review" href="/z/d/html/4806.html" rel="external">
          "Pregestational (preexisting) diabetes mellitus: Obstetric issues and management", section on 'Glycemic management'
         </a>
         .)
        </p>
        <p>
         Two-thirds of congenital anomalies in IMD involve either the cardiovascular system or central nervous system (CNS).
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Cardiac
         </strong>
         – Cardiovascular malformations occur in 3 to 9 percent of diabetic pregnancies [
         <a href="#rid2">
          2,28
         </a>
         ]. Reported cardiac defects in this population include  (
         <a class="graphic graphic_table graphicRef62158" href="/z/d/graphic/62158.html" rel="external">
          table 1
         </a>
         ) [
         <a href="#rid24">
          24,25,28,29
         </a>
         ]:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Atrial septal defects (see
         <a class="medical medical_review" href="/z/d/html/5754.html" rel="external">
          "Isolated atrial septal defects (ASDs) in children: Classification, clinical features, and diagnosis"
         </a>
         )
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Ventricular septal defect (VSD) (see
         <a class="medical medical_review" href="/z/d/html/5787.html" rel="external">
          "Isolated ventricular septal defects (VSDs) in infants and children: Anatomy, clinical features, and diagnosis"
         </a>
         )
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Patent ductus arteriosus (PDA) (see
         <a class="medical medical_review" href="/z/d/html/1421.html" rel="external">
          "Clinical manifestations and diagnosis of patent ductus arteriosus (PDA) in term infants, children, and adults"
         </a>
         )
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Transposition of the great arteries (TGA) (see
         <a class="medical medical_review" href="/z/d/html/14374.html" rel="external">
          "D-transposition of the great arteries (D-TGA): Anatomy, clinical features, and diagnosis"
         </a>
         )
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Coarctation of the aorta
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Hypoplastic left heart syndrome and other single ventricle defects (see
         <a class="medical medical_review" href="/z/d/html/14370.html" rel="external">
          "Hypoplastic left heart syndrome: Anatomy, clinical features, and diagnosis"
         </a>
         )
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Double outlet right ventricle (DORV)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Truncus arteriosus (see
         <a class="medical medical_review" href="/z/d/html/14588.html" rel="external">
          "Truncus arteriosus"
         </a>
         )
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Tricuspid atresia (see
         <a class="medical medical_review" href="/z/d/html/14587.html" rel="external">
          "Tricuspid valve atresia"
         </a>
         )
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Pulmonic stenosis (see
         <a class="medical medical_review" href="/z/d/html/14578.html" rel="external">
          "Pulmonic stenosis in infants and children: Clinical manifestations and diagnosis"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          CNS
         </strong>
         – Various types of CNS malformations have been reported in IMD, including  (
         <a class="graphic graphic_table graphicRef62158" href="/z/d/graphic/62158.html" rel="external">
          table 1
         </a>
         ) [
         <a href="#rid25">
          25,26,30,31
         </a>
         ]:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Myelomeningocele (spina bifida) (see
         <a class="medical medical_review" href="/z/d/html/6170.html" rel="external">
          "Myelomeningocele (spina bifida): Anatomy, clinical manifestations, and complications"
         </a>
         )
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Other neural tube defects, including closed spinal dysraphism (see
         <a class="medical medical_review" href="/z/d/html/460.html" rel="external">
          "Neural tube defects: Overview of prenatal screening, evaluation, and pregnancy management"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/14405.html" rel="external">
          "Closed spinal dysraphism: Pathogenesis and types"
         </a>
         )
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Anencephaly (see
         <a class="medical medical_review" href="/z/d/html/16869.html" rel="external">
          "Anencephaly"
         </a>
         )
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Encephalocele (see
         <a class="medical medical_review" href="/z/d/html/6171.html" rel="external">
          "Primary (congenital) encephalocele"
         </a>
         )
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Holoprosencephaly (see
         <a class="medical medical_review" href="/z/d/html/2920.html" rel="external">
          "Overview of craniofacial clefts and holoprosencephaly", section on 'Holoprosencephaly'
         </a>
         )
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Caudal regression syndrome, which consists of a spectrum of structural defects of the caudal region, including incomplete development of the sacrum and, to a lesser degree, the lumbar vertebrae  (
         <a class="graphic graphic_picture graphicRef72545" href="/z/d/graphic/72545.html" rel="external">
          picture 2
         </a>
         ); most cases occur in IMD [
         <a href="#rid32">
          32
         </a>
         ] (see
         <a class="medical medical_review" href="/z/d/html/14405.html" rel="external">
          "Closed spinal dysraphism: Pathogenesis and types", section on 'Caudal regression or sacral agenesis'
         </a>
         )
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Microcephaly (see
         <a class="medical medical_review" href="/z/d/html/2839.html" rel="external">
          "Microcephaly in infants and children: Etiology and evaluation"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Other
         </strong>
         – Other anomalies include  (
         <a class="graphic graphic_table graphicRef62158" href="/z/d/graphic/62158.html" rel="external">
          table 1
         </a>
         ) [
         <a href="#rid24">
          24,25
         </a>
         ]:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Flexion contracture of the limbs.
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Vertebral anomalies.
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Cleft palate.
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Intestinal anomalies including small left colon syndrome, which occurs primarily in infants of mothers with diabetes [
         <a href="#rid33">
          33
         </a>
         ]. Small colon syndrome is a rare condition that presents as a transient inability to pass meconium, which resolves spontaneously.
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Genitourinary abnormalities (eg, hydronephrosis, ureteral duplication, renal agenesis).
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H11">
         <span class="h2">
          Prematurity
         </span>
         <span class="headingEndMark">
          —
         </span>
         Spontaneous and medically indicated preterm delivery occur more frequently in diabetic than nondiabetic pregnancies [
         <a href="#rid1">
          1,2
         </a>
         ]. Preterm labor and timing of delivery in diabetic pregnancies are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/4800.html" rel="external">
          "Gestational diabetes mellitus: Obstetric issues and management", section on 'Timing of birth'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/94859.html" rel="external">
          "Pregestational (preexisting) diabetes: Preconception counseling, evaluation, and management"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4806.html" rel="external">
          "Pregestational (preexisting) diabetes mellitus: Obstetric issues and management", section on 'Preterm birth'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H12">
         <span class="h2">
          Perinatal asphyxia
         </span>
         <span class="headingEndMark">
          —
         </span>
         IMD are at increased risk for perinatal asphyxia due to the effects of intrauterine hypoxemia, macrosomia (failure to progress and shoulder dystocia), and associated cardiac and neurologic conditions. In population-based study of &gt;55,000 IDM patients, perinatal asphyxia occurred in 1.1 percent of deliveries [
         <a href="#rid2">
          2
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/4975.html" rel="external">
          "Perinatal asphyxia in term and late preterm infants"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H13">
         <span class="h2">
          Macrosomia
         </span>
         <span class="headingEndMark">
          —
         </span>
         Macrosomia or LGA (defined as birth weight [BW] &gt;4000 g or &gt;90
         <sup>
          th
         </sup>
         percentile for gestational age), is a common complication of diabetic pregnancies. The incidence is greatest in infants born to mothers with PGDM [
         <a href="#rid1">
          1,2,6,34,35
         </a>
         ].
        </p>
        <p>
         Macrosomia in IMD newborns is associated with disproportionate growth, resulting in an increased ponderal index (ie, higher body fat), higher chest-to-head and shoulder-to-head ratio, and thicker upper extremity skinfolds compared with non-IMD newborns of similar weight and length [
         <a href="#rid34">
          34-37
         </a>
         ]. Macrosomic IMD newborns typically appear large and plethoric at birth, with excessive fat accumulation in the abdominal and scapular regions  (
         <a class="graphic graphic_picture graphicRef54212" href="/z/d/graphic/54212.html" rel="external">
          picture 1
         </a>
         ).
        </p>
        <p>
         Infants with macrosomia are more likely than those who are not macrosomic to have hyperbilirubinemia, hypoglycemia, acidosis, respiratory distress, shoulder dystocia, and brachial plexus injury [
         <a href="#rid35">
          35,38
         </a>
         ]. Additional details about fetal macrosomia and LGA infants are provided separately. (See
         <a class="medical medical_review" href="/z/d/html/4443.html" rel="external">
          "Fetal macrosomia"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5059.html" rel="external">
          "Large for gestational age (LGA) newborn"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H14">
         <span class="h2">
          Birth injury
         </span>
         <span class="headingEndMark">
          —
         </span>
         Macrosomia predisposes to birth injury, especially shoulder dystocia. Shoulder dystocia occurs in nearly one-third of infants of mothers with diabetes with macrosomia [
         <a href="#rid39">
          39
         </a>
         ] and is associated with increased risk of brachial plexus injury, clavicular or humeral fractures, perinatal asphyxia, and, less often, cephalohematoma, subdural hemorrhage, or facial palsy [
         <a href="#rid3">
          3,24,40
         </a>
         ]. The risk of shoulder dystocia is also increased by the disproportionate growth that occurs in macrosomic infants, resulting in a higher chest-to-head and shoulder-to-head ratio than infants of mothers without diabetes [
         <a href="#rid41">
          41
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5031.html" rel="external">
          "Neonatal birth injuries"
         </a>
         .)
        </p>
        <p>
         The timing and route of delivery of infants of mothers with diabetes who are at risk for shoulder dystocia are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/4806.html" rel="external">
          "Pregestational (preexisting) diabetes mellitus: Obstetric issues and management", section on 'Route'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4800.html" rel="external">
          "Gestational diabetes mellitus: Obstetric issues and management", section on 'Route of birth'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H16">
         <span class="h2">
          Respiratory distress
         </span>
        </p>
        <p class="headingAnchor" id="H362813907">
         <span class="h3">
          Respiratory distress syndrome
         </span>
         <span class="headingEndMark">
          —
         </span>
         RDS due to surfactant deficiency occurs more frequently in infants of mothers with diabetes for the following two reasons [
         <a href="#rid1">
          1,3,24,25,42
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         IMD are more likely to be delivered prematurely than infants born to mothers without diabetes. (See
         <a class="local">
          'Prematurity'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         At a given gestational age, IMD are more likely to develop RDS because maternal hyperglycemia appears to impair or delay surfactant synthesis. The proposed underlying mechanism is neonatal hyperinsulinemia, which interferes with the induction of lung maturation by glucocorticoids [
         <a href="#rid43">
          43-45
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         However, in preterm infants born to mothers with well-controlled DM, the risk of RDS approaches that of infants born to mothers without diabetes at a similar gestational age [
         <a href="#rid46">
          46-48
         </a>
         ].
        </p>
        <p>
         The clinical manifestations, diagnosis, prevention, and management of RDS are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/5055.html" rel="external">
          "Respiratory distress syndrome (RDS) in the newborn: Clinical features and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4997.html" rel="external">
          "Respiratory distress syndrome (RDS) in preterm infants: Management"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H17">
         <span class="h3">
          Other causes of respiratory distress
         </span>
         <span class="headingEndMark">
          —
         </span>
         In addition to RDS, other causes of respiratory distress in infants of mothers with diabetes include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Transient tachypnea of the newborn (TTN) – TTN occurs two to three times more commonly in IMD than in infants born to mothers without diabetes [
         <a href="#rid24">
          24,49
         </a>
         ]. The mechanism may be related to reduced fluid clearance in the diabetic fetal lung. Cesarean delivery, which is more frequently performed in diabetic versus nondiabetic pregnancies, may be a contributing factor [
         <a href="#rid1">
          1,50
         </a>
         ]. The risk of developing respiratory distress after delivery is particularly high for infants with BW &gt;4000 g [
         <a href="#rid11">
          11,38,51
         </a>
         ]. TTN is discussed in greater detail separately. (See
         <a class="medical medical_review" href="/z/d/html/5066.html" rel="external">
          "Transient tachypnea of the newborn"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Critical congenital heart disease. (See
         <a class="local">
          'Congenital abnormalities'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/5774.html" rel="external">
          "Identifying newborns with critical congenital heart disease"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Heart failure due to ventricular hypertrophy. (See
         <a class="local">
          'Ventricular hypertrophy'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H18">
         <span class="h2">
          Metabolic complications
         </span>
         <span class="headingEndMark">
          —
         </span>
         Infants of mothers with diabetes are at increased risk for metabolic complications in the newborn period. The most common are hypoglycemia, hypocalcemia, and hypomagnesemia.
        </p>
        <p class="headingAnchor" id="H19">
         <span class="h3">
          Hypoglycemia
         </span>
         <span class="headingEndMark">
          —
         </span>
         Neonatal hypoglycemia (defined as blood glucose levels below 40 mg/dL [2.2 mmol/L] in the first 24 hours after birth) occurs frequently in IMD. Strict glycemic control during pregnancy decreases but does not eliminate the risk of neonatal hypoglycemia [
         <a href="#rid52">
          52-55
         </a>
         ]. LGA infants are particularly likely to develop hypoglycemia [
         <a href="#rid1">
          1,56,57
         </a>
         ]. Small for gestational age (SGA) infants are also at increased risk for persistent hypoglycemia because glycogen stores are reduced, and hyperinsulinemia impairs the ability to mobilize hepatic glycogen [
         <a href="#rid58">
          58
         </a>
         ].
        </p>
        <p>
         The onset of hypoglycemia typically occurs within the first few hours after birth. Thus, these infants require close blood glucose monitoring after delivery and frequently need enteral or parenteral glucose supplementation. In SGA infants, hypoglycemia may last longer than two to four days and may require more prolonged and higher rates of glucose infusion. The clinical manifestations, evaluation, and management of neonatal hypoglycemia are discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/5053.html" rel="external">
          "Pathogenesis, screening, and diagnosis of neonatal hypoglycemia"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/101425.html" rel="external">
          "Management and outcome of neonatal hypoglycemia"
         </a>
         .)
        </p>
        <p>
         Hypoglycemia is caused by persistent hyperinsulinemia in the newborn after interruption of the intrauterine glucose supply from the mother. Although there are no data on the caloric needs of IMD once glycemic control is established, it appears that the caloric needs of these infants are similar to those of infants of mothers without diabetes, and that subsequent weight loss and gain is self-regulated by the infant. However, offspring of diabetic pregnancies appear to be at risk for excess weight gain during childhood. (See
         <a class="local">
          'Altered glucose metabolism and obesity'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H20">
         <span class="h3">
          Hypocalcemia
         </span>
         <span class="headingEndMark">
          —
         </span>
         Hypocalcemia occurs in approximately 5 percent of IMD, though some studies have reported rates as high as 30 percent [
         <a href="#rid24">
          24,59
         </a>
         ]. The highest risk is in infants born to mothers with poorly controlled diabetes [
         <a href="#rid59">
          59
         </a>
         ].
        </p>
        <p>
         Serum calcium levels typically reach a nadir between 24 and 72 hours after birth. Hypocalcemia usually is asymptomatic and resolves without treatment [
         <a href="#rid24">
          24
         </a>
         ]. As a result, routine screening is not necessary. However, calcium levels should be measured in infants with signs of hypocalcemia (jitteriness, lethargy, apnea, tachypnea, or seizures, and in those with prematurity, asphyxia, respiratory distress).
        </p>
        <p>
         The clinical manifestations, evaluation, and management of neonatal hypocalcemia are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/5060.html" rel="external">
          "Neonatal hypocalcemia"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H21">
         <span class="h3">
          Hypomagnesemia
         </span>
         <span class="headingEndMark">
          —
         </span>
         Hypomagnesemia occurs in up to 40 percent of IMD within the first three days after birth [
         <a href="#rid60">
          60,61
         </a>
         ]. It has been proposed that low neonatal levels reflect maternal hypomagnesemia caused by increased urinary loss secondary to diabetes. Prematurity can also be a contributing factor.
        </p>
        <p>
         Hypomagnesemia usually is transient and asymptomatic and, thus, usually does not require treatment. However, hypomagnesemia can reduce both parathyroid hormone (PTH) secretion and PTH responsiveness [
         <a href="#rid13">
          13,62
         </a>
         ]. As a result, in some neonates with both hypocalcemia and hypomagnesemia, the hypocalcemia may not respond to treatment until the hypomagnesemia is corrected [
         <a href="#rid63">
          63
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H22">
         <span class="h2">
          Polycythemia
         </span>
         <span class="headingEndMark">
          —
         </span>
         Polycythemia, defined as a central venous hematocrit of &gt;65 percent, is more likely in IMD compared with infants whose mothers are not diabetic [
         <a href="#rid1">
          1
         </a>
         ]. In a case series of 276 IMD newborns, 5 percent had documented polycythemia [
         <a href="#rid24">
          24
         </a>
         ]. The underlying pathogenesis is due to increased erythropoietin concentrations caused by chronic fetal hypoxemia [
         <a href="#rid18">
          18,19
         </a>
         ]. Delayed cord clamping may contribute to the high hematocrit [
         <a href="#rid64">
          64
         </a>
         ].
        </p>
        <p>
         To detect polycythemia, the hematocrit should be measured within 12 hours of birth.
        </p>
        <p>
         Polycythemia may lead to hyperviscosity syndrome, including vascular sludging, ischemia, and infarction of vital organs. Hyperviscosity is thought to contribute to the increased risk of renal vein thrombosis seen in IMD [
         <a href="#rid65">
          65
         </a>
         ].
        </p>
        <p>
         The clinical manifestations, management, and outcome of polycythemia are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/5940.html" rel="external">
          "Neonatal polycythemia"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H20047970">
         <span class="h2">
          Low iron stores
         </span>
         <span class="headingEndMark">
          —
         </span>
         The combined erythrocyte and storage iron pools are lower in infants of mothers with diabetes. The degree of low iron stores at birth is inversely related to the degree of polycythemia, suggesting a shunting of fetal iron into the red cell mass [
         <a href="#rid66">
          66
         </a>
         ]. It is thought that the excess iron in the polycythemic red blood cell (RBC) mass is recirculated as the excess RBCs break down. Thus, iron supplementation is generally not necessary.
        </p>
        <p class="headingAnchor" id="H23">
         <span class="h2">
          Hyperbilirubinemia
         </span>
         <span class="headingEndMark">
          —
         </span>
         Hyperbilirubinemia occurs in 10 to 30 percent of infants of mothers with diabetes [
         <a href="#rid24">
          24
         </a>
         ]. The risk is particularly high in preterm neonates. In addition to prematurity, other factors associated with neonatal jaundice include poor maternal glycemic control, macrosomia, and polycythemia [
         <a href="#rid60">
          60,67
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5008.html" rel="external">
          "Unconjugated hyperbilirubinemia in term and late preterm newborns: Screening"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5063.html" rel="external">
          "Unconjugated hyperbilirubinemia in term and late preterm newborns: Initial management"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H24">
         <span class="h2">
          Ventricular hypertrophy
         </span>
         <span class="headingEndMark">
          —
         </span>
         IMD are at increased risk for transient left ventricular hypertrophy (LVH) [
         <a href="#rid1">
          1,68,69
         </a>
         ]. It is usually a benign finding that does not cause clinical symptoms and resolves spontaneously over the first year of life [
         <a href="#rid70">
          70
         </a>
         ]. However, a small minority of affected infants may develop respiratory distress or signs of heart failure. The chest radiograph may show cardiomegaly; but LVH is best detected by echocardiography. The characteristic echocardiographic finding is marked thickening of the interventricular septum, whereas the free wall of the left ventricle is relatively spared. Given the benign natural history, screening echocardiograms are generally not necessary if the infant is otherwise well and has no clinical signs of heart disease (including normal pulse oximetry screen).
        </p>
        <p>
         LVH resolves as plasma insulin concentrations normalize. Symptomatic infants typically recover after two to three weeks of supportive care, and echocardiographic findings resolve within 6 to 12 months [
         <a href="#rid71">
          71
         </a>
         ].
        </p>
        <p>
         Like most neonatal complications in IMD, ventricular hypertrophy is most likely to occur if the mother had poor glycemic control during pregnancy [
         <a href="#rid72">
          72-74
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H714043">
         <span class="h1">
          OVERVIEW OF NEONATAL MANAGEMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         The management of infants of mothers with diabetes (IMD) focuses on anticipating and treating complications associated with maternal hyperglycemia. The risk of complications varies depending on the gestational age (GA), birth weight (BW), and the degree and severity of maternal hyperglycemia as discussed above. (See
         <a class="local">
          'Impact of maternal diabetes status'
         </a>
         above and
         <a class="local">
          'Neonatal complications'
         </a>
         above.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Delivery room care
         </strong>
         – Immediately after delivery, routine neonatal care is provided that includes drying, clearing the airway of secretions, maintaining warmth, and a rapid assessment of the infant's clinical status based on heart rate, respiratory effort, tone, and an examination to identify any major congenital anomaly. The need for further intervention is based on this initial evaluation. If the infant does not require additional resuscitation, the infant should be given to the mother for skin-to-skin care and initiation of breastfeeding in the delivery room. (See
         <a class="medical medical_review" href="/z/d/html/5015.html" rel="external">
          "Neonatal resuscitation in the delivery room", section on 'Resuscitation'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5068.html" rel="external">
          "Overview of the routine management of the healthy newborn infant", section on 'Delivery room care'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Screening for common complications
         </strong>
         –
         <strong>
         </strong>
         Routine newborn screening should be performed for all IMD as in the general newborn population. This includes the "blood spot" screening panel for genetic and metabolic conditions, pulse oximetry screening to detect critical congenital heart disease, routine screening for hyperbilirubinemia, and screening for hearing loss. These screening tests are discussed in greater detail separately. (See
         <a class="medical medical_review" href="/z/d/html/4980.html" rel="external">
          "Overview of newborn screening"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5068.html" rel="external">
          "Overview of the routine management of the healthy newborn infant", section on 'Routine newborn screening'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Additional screening for IMD newborns includes:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Screening for hypoglycemia, as discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/5053.html" rel="external">
          "Pathogenesis, screening, and diagnosis of neonatal hypoglycemia", section on 'Screening'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Screening for polycythemia by measuring the venous hematocrit within 12 hours after delivery. (See
         <a class="medical medical_review" href="/z/d/html/5940.html" rel="external">
          "Neonatal polycythemia", section on 'Diagnosis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Routine measurement of calcium and magnesium levels is generally
         <strong>
          not
         </strong>
         necessary; however, levels should be checked if the newborn has concerning clinical signs of hypocalcemia or hypomagnesemia (eg, seizure or jitteriness). (See
         <a class="local">
          'Hypocalcemia'
         </a>
         above and
         <a class="local">
          'Hypomagnesemia'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/5060.html" rel="external">
          "Neonatal hypocalcemia"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         If there are no significant complications that require further intervention, routine newborn care should be provided. (See
         <a class="medical medical_review" href="/z/d/html/5068.html" rel="external">
          "Overview of the routine management of the healthy newborn infant"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Management of common complications
         </strong>
         – Details of the management of specific complications seen in IMD are provided in separate topic reviews:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Critical congenital heart disease (see
         <a class="medical medical_review" href="/z/d/html/5785.html" rel="external">
          "Diagnosis and initial management of cyanotic heart disease in the newborn", section on 'Initial management'
         </a>
         )
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Respiratory distress syndrome (see
         <a class="medical medical_review" href="/z/d/html/4997.html" rel="external">
          "Respiratory distress syndrome (RDS) in preterm infants: Management"
         </a>
         )
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Transient tachypnea of the newborn (TTN) (see
         <a class="medical medical_review" href="/z/d/html/5066.html" rel="external">
          "Transient tachypnea of the newborn", section on 'Management'
         </a>
         )
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Hyperbilirubinemia (see
         <a class="medical medical_review" href="/z/d/html/5063.html" rel="external">
          "Unconjugated hyperbilirubinemia in term and late preterm newborns: Initial management"
         </a>
         )
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Hypoglycemia (see
         <a class="medical medical_review" href="/z/d/html/101425.html" rel="external">
          "Management and outcome of neonatal hypoglycemia"
         </a>
         )
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Hypocalcemia (see
         <a class="medical medical_review" href="/z/d/html/5060.html" rel="external">
          "Neonatal hypocalcemia", section on 'Management'
         </a>
         )
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Polycythemia (see
         <a class="medical medical_review" href="/z/d/html/5940.html" rel="external">
          "Neonatal polycythemia", section on 'Management'
         </a>
         )
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Heart failure due to ventricular hypertrophy (see
         <a class="medical medical_review" href="/z/d/html/14520.html" rel="external">
          "Heart failure in children: Management"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H713834">
         <span class="h1">
          LONG-TERM OUTCOME
         </span>
        </p>
        <p class="headingAnchor" id="H26">
         <span class="h2">
          Metabolic risks
         </span>
        </p>
        <p class="headingAnchor" id="H27">
         <span class="h3">
          Diabetes
         </span>
         <span class="headingEndMark">
          —
         </span>
         Infants of mothers with diabetes (IMD) have an increased risk of developing diabetes mellitus later in life. This risk is partly due to genetically determined factors [
         <a href="#rid75">
          75
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Risk of type 1 diabetes mellitus (T1DM)
         </strong>
         – The lifetime risk of T1DM is 2 percent in offspring of a mother with T1DM, 6 percent in siblings, and 65 percent by age 60 years in identical twins (versus 0.3 to 0.4 percent in individuals with no family history of T1DM) [
         <a href="#rid76">
          76
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/1800.html" rel="external">
          "Pathogenesis of type 1 diabetes mellitus"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Risk of type 2 diabetes mellitus (T2DM)
         </strong>
         – The lifetime risk for a first-degree relative of a patient with T2DM is 5 to 10 times higher than that of age- and weight-matched individuals without a family history of T2DM. (See
         <a class="medical medical_review" href="/z/d/html/1810.html" rel="external">
          "Pathogenesis of type 2 diabetes mellitus"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The development of T2DM also may be affected by the abnormal intrauterine metabolic environment of a diabetic pregnancy. Data from studies performed in Pima Indians, who have the highest rates of gestational diabetes, demonstrate that 45 percent of offspring of mothers with gestational diabetes develop T2DM between 20 and 24 years of age compared with offspring of prediabetic (9 percent) or women without diabetes (1 percent) [
         <a href="#rid77">
          77,78
         </a>
         ]. This increased risk persists despite accounting for paternal history of diabetes, age of onset of diabetes in parents, and the child's body mass index (BMI), suggesting that the intrauterine environment contributed to the development of diabetes, in addition to genetic factors. In a follow-up study, more than two-thirds of offspring of mothers with gestational diabetes developed T2DM by 34 years of age [
         <a href="#rid79">
          79
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H28">
         <span class="h3">
          Altered glucose metabolism and obesity
         </span>
         <span class="headingEndMark">
          —
         </span>
         Intrauterine exposure to hyperglycemia resulting in fetal hyperinsulinemia may affect the development of adipose tissue and pancreatic beta cells leading impaired glucose metabolism and increased risk for obesity in later childhood and/or adulthood. This can occur both in offspring of mother with pregestational and gestational diabetes [
         <a href="#rid80">
          80-90
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H713946">
         <span class="h2">
          Neurodevelopmental outcome
         </span>
         <span class="headingEndMark">
          —
         </span>
         Most of the available observational studies suggest that maternal diabetes negatively impacts cognitive development in the offspring [
         <a href="#rid91">
          91-95
         </a>
         ], though some studies have found little to no effect [
         <a href="#rid96">
          96
         </a>
         ]. However, the studies have important limitations, most notably the inability to completely control for confounding factors (eg, parental education, socioeconomic status, comorbidities).
        </p>
        <p>
         A 2016 systematic review identified 14 observational studies examining the association between maternal diabetes (pregestational or gestational) and offspring's cognitive development [
         <a href="#rid92">
          92
         </a>
         ]. Eight studies found at least one negative association. The different studies used different tools to evaluate cognitive outcomes and therefore pooling of the results was not feasible. In a representative study, mean scores on standardized intelligence tests at age 8 years of age were 3 to 7 points lower in children born to mothers with diabetes compared with the reference healthy population [
         <a href="#rid95">
          95
         </a>
         ]. However, after controlling for important confounders, the difference was no longer statistically significant.
        </p>
        <p class="headingAnchor" id="H30">
         <span class="h1">
          INFORMATION FOR PATIENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5
         <sup>
          th
         </sup>
         to 6
         <sup>
          th
         </sup>
         grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10
         <sup>
          th
         </sup>
         to 12
         <sup>
          th
         </sup>
         grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.
        </p>
        <p>
         Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Basics topics (see
         <a class="medical medical_basics" href="/z/d/html/15731.html" rel="external">
          "Patient education: Care during pregnancy for people with type 1 or type 2 diabetes (The Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Beyond the Basics topics (see
         <a class="medical medical_patient" href="/z/d/html/6722.html" rel="external">
          "Patient education: Care during pregnancy for patients with type 1 or 2 diabetes (Beyond the Basics)"
         </a>
         and
         <a class="medical medical_patient" href="/z/d/html/6735.html" rel="external">
          "Patient education: Gestational diabetes (Beyond the Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H714002">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Impact of maternal diabetes status
         </strong>
         – Diabetes in pregnancy is associated with an increased risk of fetal, neonatal, and long-term complications in offspring. The risk of complications varies considerably depending upon whether the mother has pregestational or gestational diabetes mellitus (PGDM or GDM), whether the mother is insulin-dependent, and the degree of glycemic control achieved before and during pregnancy. (See
         <a class="local">
          'Impact of maternal diabetes status'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Neonatal complications of maternal diabetes
         </strong>
         – Infants of mothers with diabetes (IMD) are at increased risk for the following adverse effects  (
         <a class="graphic graphic_table graphicRef80370" href="/z/d/graphic/80370.html" rel="external">
          table 2
         </a>
         ):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Congenital anomalies, especially cardiovascular and central nervous system (CNS) defects  (
         <a class="graphic graphic_table graphicRef62158" href="/z/d/graphic/62158.html" rel="external">
          table 1
         </a>
         ) (see
         <a class="local">
          'Congenital abnormalities'
         </a>
         above)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Prematurity (see
         <a class="local">
          'Prematurity'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/4806.html" rel="external">
          "Pregestational (preexisting) diabetes mellitus: Obstetric issues and management", section on 'Preterm birth'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Perinatal asphyxia (see
         <a class="local">
          'Perinatal asphyxia'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/4975.html" rel="external">
          "Perinatal asphyxia in term and late preterm infants"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Macrosomia or large for gestational age (defined as a birth weight [BW] &gt;4000 g or &gt;90
         <sup>
          th
         </sup>
         percentile for gestational age)  (
         <a class="graphic graphic_picture graphicRef54212" href="/z/d/graphic/54212.html" rel="external">
          picture 1
         </a>
         ) (see
         <a class="local">
          'Macrosomia'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/5059.html" rel="external">
          "Large for gestational age (LGA) newborn"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Respiratory distress (see
         <a class="local">
          'Respiratory distress'
         </a>
         above)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Hypoglycemia that generally occurs within the first few hours after birth (see
         <a class="local">
          'Hypoglycemia'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/5053.html" rel="external">
          "Pathogenesis, screening, and diagnosis of neonatal hypoglycemia"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Hypocalcemia that is generally asymptomatic (see
         <a class="local">
          'Hypocalcemia'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/5060.html" rel="external">
          "Neonatal hypocalcemia"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Polycythemia (see
         <a class="local">
          'Polycythemia'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/5940.html" rel="external">
          "Neonatal polycythemia"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Low iron stores (see
         <a class="local">
          'Low iron stores'
         </a>
         above)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Hyperbilirubinemia (see
         <a class="local">
          'Hyperbilirubinemia'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/4994.html" rel="external">
          "Unconjugated hyperbilirubinemia in neonates: Risk factors, clinical manifestations, and neurologic complications"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Transient ventricular hypertrophy that is usually asymptomatic (see
         <a class="local">
          'Ventricular hypertrophy'
         </a>
         above)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Overview of management
         </strong>
         – The management of IMD focuses on anticipating and treating complications associated with maternal hyperglycemia. The clinical assessment focuses on the respiratory and cardiac status of the infant and identifying any major congenital abnormalities  (
         <a class="graphic graphic_table graphicRef62158" href="/z/d/graphic/62158.html" rel="external">
          table 1
         </a>
         ). (See
         <a class="local">
          'Overview of neonatal management'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         In addition to routine newborn care and screening procedures, IMD newborns should undergo screening for hypoglycemia and polycythemia, as discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/5053.html" rel="external">
          "Pathogenesis, screening, and diagnosis of neonatal hypoglycemia", section on 'Screening'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5940.html" rel="external">
          "Neonatal polycythemia", section on 'Diagnosis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Additional details of the management of specific complications seen in IMD are provided in separate topic reviews:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Critical congenital heart disease (see
         <a class="medical medical_review" href="/z/d/html/5785.html" rel="external">
          "Diagnosis and initial management of cyanotic heart disease in the newborn", section on 'Initial management'
         </a>
         )
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Respiratory distress syndrome (see
         <a class="medical medical_review" href="/z/d/html/4997.html" rel="external">
          "Respiratory distress syndrome (RDS) in preterm infants: Management"
         </a>
         )
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Transient tachypnea of the newborn (TTN) (see
         <a class="medical medical_review" href="/z/d/html/5066.html" rel="external">
          "Transient tachypnea of the newborn", section on 'Management'
         </a>
         )
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Hyperbilirubinemia (see
         <a class="medical medical_review" href="/z/d/html/5063.html" rel="external">
          "Unconjugated hyperbilirubinemia in term and late preterm newborns: Initial management"
         </a>
         )
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Hypoglycemia (see
         <a class="medical medical_review" href="/z/d/html/101425.html" rel="external">
          "Management and outcome of neonatal hypoglycemia"
         </a>
         )
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Hypocalcemia (see
         <a class="medical medical_review" href="/z/d/html/5060.html" rel="external">
          "Neonatal hypocalcemia", section on 'Management'
         </a>
         )
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Polycythemia (see
         <a class="medical medical_review" href="/z/d/html/5940.html" rel="external">
          "Neonatal polycythemia", section on 'Management'
         </a>
         )
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Heart failure due to ventricular hypertrophy (see
         <a class="medical medical_review" href="/z/d/html/14520.html" rel="external">
          "Heart failure in children: Management"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Long-term outcome
         </strong>
         – Long-term data on offspring of diabetic mothers suggest that prenatal exposure to hyperglycemia increases the risk of metabolic complications later in life (eg, impaired glucose metabolism, obesity, type 2 diabetes mellitus). Most of the available observational studies suggest that maternal diabetes negatively impacts cognitive development in the offspring, although some studies have found little to no effect. (See
         <a class="local">
          'Long-term outcome'
         </a>
         above.)
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Riskin A, Itzchaki O, Bader D, et al. Perinatal Outcomes in Infants of Mothers with Diabetes in Pregnancy. Isr Med Assoc J 2020; 22:569.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Billionnet C, Mitanchez D, Weill A, et al. Gestational diabetes and adverse perinatal outcomes from 716,152 births in France in 2012. Diabetologia 2017; 60:636.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Michael Weindling A. Offspring of diabetic pregnancy: short-term outcomes. Semin Fetal Neonatal Med 2009; 14:111.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yang J, Cummings EA, O'connell C, Jangaard K. Fetal and neonatal outcomes of diabetic pregnancies. Obstet Gynecol 2006; 108:644.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kapoor N, Sankaran S, Hyer S, Shehata H. Diabetes in pregnancy: a review of current evidence. Curr Opin Obstet Gynecol 2007; 19:586.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kong L, Nilsson IAK, Gissler M, Lavebratt C. Associations of Maternal Diabetes and Body Mass Index With Offspring Birth Weight and Prematurity. JAMA Pediatr 2019; 173:371.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Battarbee AN, Venkatesh KK, Aliaga S, Boggess KA. The association of pregestational and gestational diabetes with severe neonatal morbidity and mortality. J Perinatol 2020; 40:232.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Buchanan TA, Kitzmiller JL. Metabolic interactions of diabetes and pregnancy. Annu Rev Med 1994; 45:245.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lemaitre M, Bourdon G, Bruandet A, et al. Pre-gestational diabetes and the risk of congenital heart defects in the offspring: A French nationwide study. Diabetes Metab 2023; 49:101446.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chen LJ, Chiu CH, Huang JY, et al. Maternal diabetes mellitus and birth defects in Taiwan: A 5-year nationwide population-based cohort study. J Chin Med Assoc 2023; 86:589.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mitanchez D, Burguet A, Simeoni U. Infants born to mothers with gestational diabetes mellitus: mild neonatal effects, a long-term threat to global health. J Pediatr 2014; 164:445.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mitanchez D, Yzydorczyk C, Siddeek B, et al. The offspring of the diabetic mother--short- and long-term implications. Best Pract Res Clin Obstet Gynaecol 2015; 29:256.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tyrala EE. The infant of the diabetic mother. Obstet Gynecol Clin North Am 1996; 23:221.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hornberger LK. Maternal diabetes and the fetal heart. Heart 2006; 92:1019.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Elmekkawi SF, Mansour GM, Elsafty MS, et al. Prediction of Fetal Hypertrophic Cardiomyopathy in Diabetic Pregnancies Compared with Postnatal Outcome. Clin Med Insights Womens Health 2015; 8:39.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Philips AF, Dubin JW, Matty PJ, Raye JR. Arterial hypoxemia and hyperinsulinemia in the chronically hyperglycemic fetal lamb. Pediatr Res 1982; 16:653.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nold JL, Georgieff MK. Infants of diabetic mothers. Pediatr Clin North Am 2004; 51:619.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Widness JA, Teramo KA, Clemons GK, et al. Temporal response of immunoreactive erythropoietin to acute hypoxemia in fetal sheep. Pediatr Res 1986; 20:15.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Widness JA, Teramo KA, Clemons GK, et al. Direct relationship of antepartum glucose control and fetal erythropoietin in human type 1 (insulin-dependent) diabetic pregnancy. Diabetologia 1990; 33:378.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sarikabadayi YU, Aydemir O, Aydemir C, et al. Umbilical cord oxidative stress in infants of diabetic mothers and its relation to maternal hyperglycemia. J Pediatr Endocrinol Metab 2011; 24:671.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lappas M, Hiden U, Desoye G, et al. The role of oxidative stress in the pathophysiology of gestational diabetes mellitus. Antioxid Redox Signal 2011; 15:3061.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Topcuoglu S, Karatekin G, Yavuz T, et al. The relationship between the oxidative stress and the cardiac hypertrophy in infants of diabetic mothers. Diabetes Res Clin Pract 2015; 109:104.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Escobar J, Teramo K, Stefanovic V, et al. Amniotic fluid oxidative and nitrosative stress biomarkers correlate with fetal chronic hypoxia in diabetic pregnancies. Neonatology 2013; 103:193.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cordero L, Treuer SH, Landon MB, Gabbe SG. Management of infants of diabetic mothers. Arch Pediatr Adolesc Med 1998; 152:249.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Becerra JE, Khoury MJ, Cordero JF, Erickson JD. Diabetes mellitus during pregnancy and the risks for specific birth defects: a population-based case-control study. Pediatrics 1990; 85:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Correa A, Gilboa SM, Besser LM, et al. Diabetes mellitus and birth defects. Am J Obstet Gynecol 2008; 199:237.e1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Weintrob N, Karp M, Hod M. Short- and long-range complications in offspring of diabetic mothers. J Diabetes Complications 1996; 10:294.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wren C, Birrell G, Hawthorne G. Cardiovascular malformations in infants of diabetic mothers. Heart 2003; 89:1217.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aloqab FW, Almajed MR, Binsanad NA, et al. Maternal diabetes as a teratogenic factor for congenital heart defects in infants of diabetic mothers. Birth Defects Res 2023; 115:764.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Khoury MJ, Becerra JE, Cordero JF, Erickson JD. Clinical-epidemiologic assessment of pattern of birth defects associated with human teratogens: application to diabetic embryopathy. Pediatrics 1989; 84:658.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kokhanov A. Congenital Abnormalities in the Infant of a Diabetic Mother. Neoreviews 2022; 23:e319.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mills JL. Malformations in infants of diabetic mothers. Teratology 1982; 25:385.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ellis H, Kumar R, Kostyrka B. Neonatal small left colon syndrome in the offspring of diabetic mothers-an analysis of 105 children. J Pediatr Surg 2009; 44:2343.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Persson M, Pasupathy D, Hanson U, Norman M. Birth size distribution in 3,705 infants born to mothers with type 1 diabetes: a population-based study. Diabetes Care 2011; 34:1145.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Persson M, Fadl H, Hanson U, Pasupathy D. Disproportionate body composition and neonatal outcome in offspring of mothers with and without gestational diabetes mellitus. Diabetes Care 2013; 36:3543.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ballard JL, Rosenn B, Khoury JC, Miodovnik M. Diabetic fetal macrosomia: significance of disproportionate growth. J Pediatr 1993; 122:115.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McFarland MB, Trylovich CG, Langer O. Anthropometric differences in macrosomic infants of diabetic and nondiabetic mothers. J Matern Fetal Med 1998; 7:292.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Esakoff TF, Cheng YW, Sparks TN, Caughey AB. The association between birthweight 4000 g or greater and perinatal outcomes in patients with and without gestational diabetes mellitus. Am J Obstet Gynecol 2009; 200:672.e1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Acker DB, Sachs BP, Friedman EA. Risk factors for shoulder dystocia in the average-weight infant. Obstet Gynecol 1986; 67:614.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gregory KD, Henry OA, Ramicone E, et al. Maternal and infant complications in high and normal weight infants by method of delivery. Obstet Gynecol 1998; 92:507.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nesbitt TS, Gilbert WM, Herrchen B. Shoulder dystocia and associated risk factors with macrosomic infants born in California. Am J Obstet Gynecol 1998; 179:476.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Robert MF, Neff RK, Hubbell JP, et al. Association between maternal diabetes and the respiratory-distress syndrome in the newborn. N Engl J Med 1976; 294:357.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bourbon JR, Farrell PM. Fetal lung development in the diabetic pregnancy. Pediatr Res 1985; 19:253.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gewolb IH, O'Brien J. Surfactant secretion by type II pneumocytes is inhibited by high glucose concentrations. Exp Lung Res 1997; 23:245.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gewolb IH. Effect of high glucose on fetal lung maturation at different times in gestation. Exp Lung Res 1996; 22:201.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Werner EF, Romano ME, Rouse DJ, et al. Association of Gestational Diabetes Mellitus With Neonatal Respiratory Morbidity. Obstet Gynecol 2019; 133:349.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bental Y, Reichman B, Shiff Y, et al. Impact of maternal diabetes mellitus on mortality and morbidity of preterm infants (24-33 weeks' gestation). Pediatrics 2011; 128:e848.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Piper JM. Lung maturation in diabetes in pregnancy: if and when to test. Semin Perinatol 2002; 26:206.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Persson B, Hanson U. Neonatal morbidities in gestational diabetes mellitus. Diabetes Care 1998; 21 Suppl 2:B79.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pinter E, Peyman JA, Snow K, et al. Effects of maternal diabetes on fetal rat lung ion transport. Contribution of alveolar and bronchiolar epithelial cells to Na+,K(+)-ATPase expression. J Clin Invest 1991; 87:821.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Das S, Irigoyen M, Patterson MB, et al. Neonatal outcomes of macrosomic births in diabetic and non-diabetic women. Arch Dis Child Fetal Neonatal Ed 2009; 94:F419.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yamamoto JM, Corcoy R, Donovan LE, et al. Maternal glycaemic control and risk of neonatal hypoglycaemia in Type 1 diabetes pregnancy: a secondary analysis of the CONCEPTT trial. Diabet Med 2019; 36:1046.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cowett RM, Susa JB, Giletti B, et al. Glucose kinetics in infants of diabetic mothers. Am J Obstet Gynecol 1983; 146:781.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aucott SW, Williams TG, Hertz RH, Kalhan SC. Rigorous management of insulin-dependent diabetes mellitus during pregnancy. Acta Diabetol 1994; 31:126.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Arimitsu T, Kasuga Y, Ikenoue S, et al. Risk factors of neonatal hypoglycemia in neonates born to mothers with gestational diabetes. Endocr J 2023; 70:511.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           HAPO Study Cooperative Research Group, Metzger BE, Lowe LP, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008; 358:1991.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Metzger BE, Persson B, Lowe LP, et al. Hyperglycemia and adverse pregnancy outcome study: neonatal glycemia. Pediatrics 2010; 126:e1545.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kalhan SC, Savin SM, Adam PA. Attenuated glucose production rate in newborn infants of insulin-dependent diabetic mothers. N Engl J Med 1977; 296:375.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Demarini S, Mimouni F, Tsang RC, et al. Impact of metabolic control of diabetes during pregnancy on neonatal hypocalcemia: a randomized study. Obstet Gynecol 1994; 83:918.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rosenn B, Miodovnik M, Tsang R. Common clinical manifestations of maternal diabetes in newborn infants: implications for the practicing pediatrician. Pediatr Ann 1996; 25:215.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tsang RC, Strub R, Brown DR, et al. Hypomagnesemia in infants of diabetic mothers: perinatal studies. J Pediatr 1976; 89:115.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Freitag JJ, Martin KJ, Conrades MB, et al. Evidence for skeletal resistance to parathyroid hormone in magnesium deficiency. Studies in isolated perfused bone. J Clin Invest 1979; 64:1238.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Banerjee S, Mimouni FB, Mehta R, et al. Lower whole blood ionized magnesium concentrations in hypocalcemic infants of gestational diabetic mothers. Magnes Res 2003; 16:127.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           O W, Omori K, Emmanouilides GC, Phelps DL. Placenta to lamb fetus transfusion in utero during acute hypoxia. Am J Obstet Gynecol 1975; 122:316.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kuhle S, Massicotte P, Chan A, Mitchell L. A case series of 72 neonates with renal vein thrombosis. Data from the 1-800-NO-CLOTS Registry. Thromb Haemost 2004; 92:729.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Georgieff MK, Landon MB, Mills MM, et al. Abnormal iron distribution in infants of diabetic mothers: spectrum and maternal antecedents. J Pediatr 1990; 117:455.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Peevy KJ, Landaw SA, Gross SJ. Hyperbilirubinemia in infants of diabetic mothers. Pediatrics 1980; 66:417.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ullmo S, Vial Y, Di Bernardo S, et al. Pathologic ventricular hypertrophy in the offspring of diabetic mothers: a retrospective study. Eur Heart J 2007; 28:1319.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Veille JC, Sivakoff M, Hanson R, Fanaroff AA. Interventricular septal thickness in fetuses of diabetic mothers. Obstet Gynecol 1992; 79:51.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Monda E, Verrillo F, Altobelli I, et al. Natural history of left ventricular hypertrophy in infants of diabetic mothers. Int J Cardiol 2022; 350:77.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Way GL, Wolfe RR, Eshaghpour E, et al. The natural history of hypertrophic cardiomyopathy in infants of diabetic mothers. J Pediatr 1979; 95:1020.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mace S, Hirschfield SS, Riggs T, et al. Echocardiographic abnormalities in infants of diabetic mothers. J Pediatr 1979; 95:1013.
          </a>
         </li>
         <li class="breakAll">
          Heart Disease: A Textbook of Cardiovascular Medicine, Braunwald E (Ed), Saunders, Philadelphia 1997.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chandra T, Tripathi S, Tiwari A, et al. Role of cord blood IGF-1 and maternal HbA1c levels to predict interventricular septal hypertrophy among infants of diabetic mothers: A case-control study. Early Hum Dev 2023; 179:105751.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Reece EA, Homko CJ. Infant of the diabetic mother. Semin Perinatol 1994; 18:459.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Redondo MJ, Jeffrey J, Fain PR, et al. Concordance for islet autoimmunity among monozygotic twins. N Engl J Med 2008; 359:2849.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pettitt DJ, Aleck KA, Baird HR, et al. Congenital susceptibility to NIDDM. Role of intrauterine environment. Diabetes 1988; 37:622.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dabelea D, Hanson RL, Bennett PH, et al. Increasing prevalence of Type II diabetes in American Indian children. Diabetologia 1998; 41:904.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dabelea D, Knowler WC, Pettitt DJ. Effect of diabetes in pregnancy on offspring: follow-up research in the Pima Indians. J Matern Fetal Med 2000; 9:83.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Silverman BL, Rizzo TA, Cho NH, Metzger BE. Long-term effects of the intrauterine environment. The Northwestern University Diabetes in Pregnancy Center. Diabetes Care 1998; 21 Suppl 2:B142.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mughal MZ, Eelloo J, Roberts SA, et al. Body composition and bone status of children born to mothers with type 1 diabetes mellitus. Arch Dis Child 2010; 95:281.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sobngwi E, Boudou P, Mauvais-Jarvis F, et al. Effect of a diabetic environment in utero on predisposition to type 2 diabetes. Lancet 2003; 361:1861.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Touger L, Looker HC, Krakoff J, et al. Early growth in offspring of diabetic mothers. Diabetes Care 2005; 28:585.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vääräsmäki M, Pouta A, Elliot P, et al. Adolescent manifestations of metabolic syndrome among children born to women with gestational diabetes in a general-population birth cohort. Am J Epidemiol 2009; 169:1209.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vohr BR, McGarvey ST, Tucker R. Effects of maternal gestational diabetes on offspring adiposity at 4-7 years of age. Diabetes Care 1999; 22:1284.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Clausen TD, Mathiesen ER, Hansen T, et al. Overweight and the metabolic syndrome in adult offspring of women with diet-treated gestational diabetes mellitus or type 1 diabetes. J Clin Endocrinol Metab 2009; 94:2464.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Page KA, Romero A, Buchanan TA, Xiang AH. Gestational diabetes mellitus, maternal obesity, and adiposity in offspring. J Pediatr 2014; 164:807.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Logan KM, Gale C, Hyde MJ, et al. Diabetes in pregnancy and infant adiposity: systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed 2017; 102:F65.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lawlor DA, Lichtenstein P, Långström N. Association of maternal diabetes mellitus in pregnancy with offspring adiposity into early adulthood: sibling study in a prospective cohort of 280,866 men from 248,293 families. Circulation 2011; 123:258.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mantzorou M, Papandreou D, Pavlidou E, et al. Maternal Gestational Diabetes Is Associated with High Risk of Childhood Overweight and Obesity: A Cross-Sectional Study in Pre-School Children Aged 2-5 Years. Medicina (Kaunas) 2023; 59.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rizzo TA, Dooley SL, Metzger BE, et al. Prenatal and perinatal influences on long-term psychomotor development in offspring of diabetic mothers. Am J Obstet Gynecol 1995; 173:1753.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Adane AA, Mishra GD, Tooth LR. Diabetes in Pregnancy and Childhood Cognitive Development: A Systematic Review. Pediatrics 2016; 137.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bytoft B, Knorr S, Vlachova Z, et al. Long-term Cognitive Implications of Intrauterine Hyperglycemia in Adolescent Offspring of Women With Type 1 Diabetes (the EPICOM Study). Diabetes Care 2016; 39:1356.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sells CJ, Robinson NM, Brown Z, Knopp RH. Long-term developmental follow-up of infants of diabetic mothers. J Pediatr 1994; 125:S9.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fraser A, Nelson SM, Macdonald-Wallis C, Lawlor DA. Associations of existing diabetes, gestational diabetes, and glycosuria with offspring IQ and educational attainment: the Avon Longitudinal Study of Parents and Children. Exp Diabetes Res 2012; 2012:963735.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Boghossian NS, Hansen NI, Bell EF, et al. Outcomes of Extremely Preterm Infants Born to Insulin-Dependent Diabetic Mothers. Pediatrics 2016; 137.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 5058 Version 35.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33236556" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Perinatal Outcomes in Infants of Mothers with Diabetes in Pregnancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28197657" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Gestational diabetes and adverse perinatal outcomes from 716,152 births in France in 2012.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19249005" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Offspring of diabetic pregnancy: short-term outcomes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16946226" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Fetal and neonatal outcomes of diabetic pregnancies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18007138" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Diabetes in pregnancy: a review of current evidence.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30801637" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Associations of Maternal Diabetes and Body Mass Index With Offspring Birth Weight and Prematurity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31591489" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : The association of pregestational and gestational diabetes with severe neonatal morbidity and mortality.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8198381" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Metabolic interactions of diabetes and pregnancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/37031733" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Pre-gestational diabetes and the risk of congenital heart defects in the offspring: A French nationwide study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/37018736" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Maternal diabetes mellitus and birth defects in Taiwan: A 5-year nationwide population-based cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24331686" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Infants born to mothers with gestational diabetes mellitus: mild neonatal effects, a long-term threat to global health.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25267399" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : The offspring of the diabetic mother--short- and long-term implications.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8684780" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : The infant of the diabetic mother.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16698822" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Maternal diabetes and the fetal heart.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26664250" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Prediction of Fetal Hypertrophic Cardiomyopathy in Diabetic Pregnancies Compared with Postnatal Outcome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7050872" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Arterial hypoxemia and hyperinsulinemia in the chronically hyperglycemic fetal lamb.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15157588" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Infants of diabetic mothers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3945512" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Temporal response of immunoreactive erythropoietin to acute hypoxemia in fetal sheep.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2199280" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Direct relationship of antepartum glucose control and fetal erythropoietin in human type 1 (insulin-dependent) diabetic pregnancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22145454" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Umbilical cord oxidative stress in infants of diabetic mothers and its relation to maternal hyperglycemia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21675877" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : The role of oxidative stress in the pathophysiology of gestational diabetes mellitus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25934526" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : The relationship between the oxidative stress and the cardiac hypertrophy in infants of diabetic mothers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23295371" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Amniotic fluid oxidative and nitrosative stress biomarkers correlate with fetal chronic hypoxia in diabetic pregnancies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9529462" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Management of infants of diabetic mothers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2404255" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Diabetes mellitus during pregnancy and the risks for specific birth defects: a population-based case-control study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18674752" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Diabetes mellitus and birth defects.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8887019" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Short- and long-range complications in offspring of diabetic mothers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12975424" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Cardiovascular malformations in infants of diabetic mothers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36919653" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Maternal diabetes as a teratogenic factor for congenital heart defects in infants of diabetic mothers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2674881" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Clinical-epidemiologic assessment of pattern of birth defects associated with human teratogens: application to diabetic embryopathy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35490182" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Congenital Abnormalities in the Infant of a Diabetic Mother.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7051398" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Malformations in infants of diabetic mothers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20006023" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Neonatal small left colon syndrome in the offspring of diabetic mothers-an analysis of 105 children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21430084" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Birth size distribution in 3,705 infants born to mothers with type 1 diabetes: a population-based study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24159180" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Disproportionate body composition and neonatal outcome in offspring of mothers with and without gestational diabetes mellitus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8419598" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Diabetic fetal macrosomia: significance of disproportionate growth.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9848695" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Anthropometric differences in macrosomic infants of diabetic and nondiabetic mothers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19376489" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : The association between birthweight 4000 g or greater and perinatal outcomes in patients with and without gestational diabetes mellitus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3960434" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Risk factors for shoulder dystocia in the average-weight infant.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9764620" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Maternal and infant complications in high and normal weight infants by method of delivery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9731856" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Shoulder dystocia and associated risk factors with macrosomic infants born in California.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1246288" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Association between maternal diabetes and the respiratory-distress syndrome in the newborn.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3885150" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Fetal lung development in the diabetic pregnancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9184791" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Surfactant secretion by type II pneumocytes is inhibited by high glucose concentrations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8706636" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Effect of high glucose on fetal lung maturation at different times in gestation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30633135" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Association of Gestational Diabetes Mellitus With Neonatal Respiratory Morbidity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21930550" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Impact of maternal diabetes mellitus on mortality and morbidity of preterm infants (24-33 weeks' gestation).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12099310" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Lung maturation in diabetes in pregnancy: if and when to test.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9704232" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Neonatal morbidities in gestational diabetes mellitus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1847938" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Effects of maternal diabetes on fetal rat lung ion transport. Contribution of alveolar and bronchiolar epithelial cells to Na+,K(+)-ATPase expression.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19531522" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Neonatal outcomes of macrosomic births in diabetic and non-diabetic women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31107983" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Maternal glycaemic control and risk of neonatal hypoglycaemia in Type 1 diabetes pregnancy: a secondary analysis of the CONCEPTT trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6346883" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Glucose kinetics in infants of diabetic mothers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7827348" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Rigorous management of insulin-dependent diabetes mellitus during pregnancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36792172" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Risk factors of neonatal hypoglycemia in neonates born to mothers with gestational diabetes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18463375" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Hyperglycemia and adverse pregnancy outcomes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21078733" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Hyperglycemia and adverse pregnancy outcome study: neonatal glycemia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/834200" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Attenuated glucose production rate in newborn infants of insulin-dependent diabetic mothers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8190431" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Impact of metabolic control of diabetes during pregnancy on neonatal hypocalcemia: a randomized study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8731489" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Common clinical manifestations of maternal diabetes in newborn infants: implications for the practicing pediatrician.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6642" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Hypomagnesemia in infants of diabetic mothers: perinatal studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/227929" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Evidence for skeletal resistance to parathyroid hormone in magnesium deficiency. Studies in isolated perfused bone.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12892383" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Lower whole blood ionized magnesium concentrations in hypocalcemic infants of gestational diabetic mothers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/236656" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Placenta to lamb fetus transfusion in utero during acute hypoxia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15467902" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : A case series of 72 neonates with renal vein thrombosis. Data from the 1-800-NO-CLOTS Registry.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2391604" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Abnormal iron distribution in infants of diabetic mothers: spectrum and maternal antecedents.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7422431" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Hyperbilirubinemia in infants of diabetic mothers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17158827" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Pathologic ventricular hypertrophy in the offspring of diabetic mothers: a retrospective study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1727586" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Interventricular septal thickness in fetuses of diabetic mothers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34968628" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Natural history of left ventricular hypertrophy in infants of diabetic mothers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/159352" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : The natural history of hypertrophic cardiomyopathy in infants of diabetic mothers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/159351" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Echocardiographic abnormalities in infants of diabetic mothers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/159351" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Echocardiographic abnormalities in infants of diabetic mothers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36933439" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Role of cord blood IGF-1 and maternal HbA1c levels to predict interventricular septal hypertrophy among infants of diabetic mothers: A case-control study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7824972" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Infant of the diabetic mother.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19109586" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Concordance for islet autoimmunity among monozygotic twins.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3360218" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Congenital susceptibility to NIDDM. Role of intrauterine environment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9726592" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Increasing prevalence of Type II diabetes in American Indian children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10757442" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Effect of diabetes in pregnancy on offspring: follow-up research in the Pima Indians.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9704242" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : Long-term effects of the intrauterine environment. The Northwestern University Diabetes in Pregnancy Center.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20335237" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Body composition and bone status of children born to mothers with type 1 diabetes mellitus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12788573" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : Effect of a diabetic environment in utero on predisposition to type 2 diabetes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15735192" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : Early growth in offspring of diabetic mothers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19363101" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : Adolescent manifestations of metabolic syndrome among children born to women with gestational diabetes in a general-population birth cohort.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10480772" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : Effects of maternal gestational diabetes on offspring adiposity at 4-7 years of age.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19417040" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : Overweight and the metabolic syndrome in adult offspring of women with diet-treated gestational diabetes mellitus or type 1 diabetes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24388326" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : Gestational diabetes mellitus, maternal obesity, and adiposity in offspring.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27231266" id="rid87" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          88 : Diabetes in pregnancy and infant adiposity: systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21220735" id="rid88" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          89 : Association of maternal diabetes mellitus in pregnancy with offspring adiposity into early adulthood: sibling study in a prospective cohort of 280,866 men from 248,293 families.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36984456" id="rid89" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          90 : Maternal Gestational Diabetes Is Associated with High Risk of Childhood Overweight and Obesity: A Cross-Sectional Study in Pre-School Children Aged 2-5 Years.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8610757" id="rid90" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          91 : Prenatal and perinatal influences on long-term psychomotor development in offspring of diabetic mothers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27244820" id="rid91" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          92 : Diabetes in Pregnancy and Childhood Cognitive Development: A Systematic Review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27271191" id="rid92" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          93 : Long-term Cognitive Implications of Intrauterine Hyperglycemia in Adolescent Offspring of Women With Type 1 Diabetes (the EPICOM Study).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8021756" id="rid93" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          94 : Long-term developmental follow-up of infants of diabetic mothers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22927834" id="rid94" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          95 : Associations of existing diabetes, gestational diabetes, and glycosuria with offspring IQ and educational attainment: the Avon Longitudinal Study of Parents and Children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27244849" id="rid95" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          96 : Outcomes of Extremely Preterm Infants Born to Insulin-Dependent Diabetic Mothers.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
